Juvenile Idiopathic Arthritis
📧 Sign up to get email alerts when something new happens for Juvenile Idiopathic Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-05-24FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) submitted by Cordavis Limited.
-
CLINICAL_TRIALS research · 2012-03-22Clinical Trial Update: Ultrasonography in Juvenile Idiopathic Arthritis
A completed clinical trial update examining the use of ultrasonography in juvenile idiopathic arthritis.
-
FDA approval · 2012-03-05FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) submitted by Redmont Pharmaceuticals, LLC.
-
CLINICAL_TRIALS research · 2012-02-20Clinical Trial Update: Coping Skills Training (CST) for Children With Chronic Health Conditions [Phase 2]
This update notes the completion of a Phase 2 clinical trial of Coping Skills Training for children with chronic health conditions, includin…
-
FDA approval · 2011-12-26FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for Humira (adalimumab) submitted by Cordavis Limited.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-12-13FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
FDA approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
CLINICAL_TRIALS withdrawal · 2011-11-11Clinical Trial Update: Ultrasound Assessment of Steroid Joint Injections in Juvenile Idiopathic Arthritis
The clinical trial evaluating ultrasound assessment of steroid joint injections in juvenile idiopathic arthritis has been withdrawn.
-
FDA approval · 2011-10-31FDA Approved: MELOXICAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Meloxicam from Aurobindo Pharma Limited. This approval updates the approved product under th…
-
FDA approval · 2011-09-19FDA Approved: NAPROXEN — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s Naproxen under Original Application, making a generic naproxen product available. It is used to relieve pain a…
-
CLINICAL_TRIALS research · 2011-09-19Clinical Trial Update: Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
A clinical trial update about a study evaluating antibodies to anti-TNF agents in Juvenile Idiopathic Arthritis. The trial status is unknown…
-
CLINICAL_TRIALS research · 2011-09-14Clinical Trial Update: Sleep Patterns in Children With and Without Juvenile Idiopathic Arthritis
This clinical trial update reports on sleep patterns in children with and without Juvenile Idiopathic Arthritis.
-
FDA approval · 2011-09-07FDA Approved: CIMZIA — Supplemental Application (UCB, Inc.)
FDA approved a supplemental application for Cimzia (certolizumab pegol) submitted by UCB, Inc. This action approves the changes described in…
-
FDA approval · 2011-08-24FDA Approved: NAPROXEN — Original Application (Exelan Pharmaceuticals, Inc.)
The FDA approved Exelan Pharmaceuticals' original ANDA for Naproxen (generic naproxen). This confirms a generic naproxen product for arthrit…
-
FDA approval · 2011-08-18FDA Approved: ORENCIA — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Orencia (abatacept) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Comparison of Two Different Methods of Delivering Local Analgesia During Intra-articular Corticosteroid Injections in Children With Juvenile Idiopathic Arthritis [Phase 3]
This Phase 3 trial compares two methods of delivering local analgesia during intra-articular corticosteroid injections in children with juve…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Juvenile Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating infliximab (Remicade) for juvenile idiopathic arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2011-04-01Clinical Trial Update: Safety, Efficacy, and Pharmacokinetics of Adalimumab in Japanese Children With Juvenile Rheumatoid Arthritis [Phase 3]
A Phase 3 trial in Japanese children with juvenile idiopathic arthritis evaluated safety, efficacy, and pharmacokinetics of adalimumab; resu…
-
FDA approval · 2011-02-17FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
The FDA approved a supplemental application for infliximab from Janssen Biotech, Inc., signaling a labeling update or expansion of its appro…
-
CLINICAL_TRIALS trial_result · 2011-02-01Clinical Trial Update: Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis [Phase 4]
Phase 4 clinical trial investigating withdrawal of etanercept after achieving disease control in Juvenile Idiopathic Arthritis.
-
FDA approval · 2010-12-28FDA Approved: INFLIXIMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved Janssen Biotech, Inc.'s supplemental application for infliximab. The approval updates the product's labeling and indications as…
-
FDA approval · 2010-12-10FDA Approved: IBUPROFEN — Original Application (Dolgencorp, Inc.)
FDA approved Dolgencorp, Inc.'s ibuprofen 200 mg tablets as an original generic application (ANDA). The approval supports OTC use for relief…
-
FDA approval · 2010-10-26FDA Approved: MELOXICAM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for MELOXICAM (meloxicam) from Zydus Pharmaceuticals USA Inc., resulting in changes to the labeling.…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated Uveitis [Phase 2]
A Phase 2 trial evaluated daclizumab (Human Anti-Tac) for Juvenile Idiopathic Arthritis-associated uveitis; the study completed and results …
-
FDA approval · 2010-07-29FDA Approved: HUMIRA — Supplemental Application (Cordavis Limited)
The FDA has approved a supplemental application for HUMIRA (adalimumab) filed by Cordavis Limited.
-
FDA approval · 2010-07-29FDA Approved: ZYBIC — Supplemental Application (Redmont Pharmaceuticals, LLC)
FDA approved a supplemental application for ZYBIC (meloxicam) from Redmont Pharmaceuticals, LLC. The action pertains to a supplemental appro…